A pharmaceutical composition comprising a tablet core or capsule fill and an opacifying coat and a polish coat, wherein the core or fill comprises 0.3 w/w% to 14.0 w/w % of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-l-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol or a pharmaceutically acceptable salt thereof, 3.0 w/w% of a disintegrant comprising croscannellose sodium, 0.5 w/w% of a glidant comprising silicon dioxide, 1.0 w/w% of a lubricant comprising magnesium stearate, and 81.0% to 95.0 w/w% of a diluent/filler comprising lactose and microcrystalline cellulose wherein the opacifying coat comprises lactose monohydrate and the polish coat comprises hydroxypropyl methylcellulose.
